Summit Therapeutics Inc. (SMMT) Insider Trading
Sector: Biotechnology · Market Cap: $12.3B · 0 insider purchases in the last 7 days
No open market insider purchases at Summit Therapeutics Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track SMMT on your watchlist.
Start for FreeAbout Summit Therapeutics Inc. Insider Trading
1 insider at Summit Therapeutics Inc. (SMMT) has purchased stock in the past 90 days, totaling $50.0M across 1 transaction (3,810,000 shares).
The most recent purchase was by CEO Zanganeh Mahkam on June 12, 2026 — a $50.0M buy of 3,810,000 shares at $13.12, bringing their total holdings to 573,883,879 shares.
Insider buying at SMMT has been lighter than usual — there were 7 purchases in the prior nine months.
SMMT is in the Biotechnology sector within the Biotechnology industry with a market cap of $12.3B.
Track SMMT insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.